B. Arslan

Is Heart-type Fatty Acid Binding Protein a Marker of Cardiac Damage in Patient with Exacerbated Chronic Obstructive Pulmonary Disease?

S. Ardıç, R. Akdemir, B. Arslan, 2020 .

C-reactive protein and hepatocellular carcinoma: analysis of its relationships to tumor factors.

B. Carr, H. Akkız, F. Doran, 2018, Clinical practice.

Characteristics of Hepatocellular Carcinoma Aggressiveness Factors in Turkish Patients

B. Carr, H. Akkız, F. Doran, 2017, Oncology.

HCC with low- and normal-serum alpha-fetoprotein levels.

B. Carr, H. Akkız, F. Doran, 2018, Clinical practice.

Inflammatory markers C-reactive protein and PLR in relation to HCC characteristics

B. Carr, H. Akkız, F. Doran, 2018, Journal of translational science.

Macroscopic Portal Vein Thrombosis in HCC Patients

B. Carr, H. Akkız, F. Doran, 2018, Canadian journal of gastroenterology & hepatology.

Child health, parasites and lower socioeconomic status: outcomes of a long-term screening, intervention and training study by health volunteers in rural nepal.

Y. Yasin, Ö. Kurt, S. Yaylaci, 2019, Acta tropica.

C-Reactive Protein and Platelet-Lymphocyte Ratio as Potential Tumor Markers in Low-Alpha-Fetoprotein Hepatocellular Carcinoma

B. Carr, H. Akkız, F. Doran, 2018, Oncology.